Trualt Bioenergy's ₹1,766 Crore Loans Earn A-/Stable Rating Amid CBG Push

CHEMICALS
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Trualt Bioenergy's ₹1,766 Crore Loans Earn A-/Stable Rating Amid CBG Push
Overview

Trualt Bioenergy Ltd secured a credit rating of IND A-/Stable for its ₹1,766 crore bank loan facilities from India Ratings. The rating acknowledges its leading ethanol market position and growth from compressed biogas (CBG) expansion. Key strengths include JVs with GAIL and Sumitomo, bolstered by IPO proceeds. However, risks like regulatory shifts and feedstock price volatility remain.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Credit Rating Assigned

India Ratings and Research has assigned an 'IND A-/Stable' long-term credit rating and 'IND A2+' short-term rating to Trualt Bioenergy Limited's bank loan facilities totaling ₹1,766 crore. These ratings were assigned on April 27, 2026.

Why This Rating Matters

A favourable credit rating signals reduced risk for lenders. This can help Trualt Bioenergy lower its borrowing costs and improve its financial flexibility, supporting its expansion plans and overall credit standing.

Trualt Bioenergy's Business and Growth

Trualt Bioenergy, formerly Triveni Bioenergy Ltd, is a leading player in India's ethanol sector, particularly in cane-based production. The company raised about ₹840 crore through an Initial Public Offering (IPO) in October 2025. Strategic joint ventures with GAIL (India) Ltd. and Sumitomo Corporation are driving its expansion into the Compressed Biogas (CBG) segment.

Key Strengths Highlighted by Rating

The 'IND A-/Stable' rating validates Trualt Bioenergy's strong market position as India's largest cane-based distillery. It supports the company's significant expansion into Compressed Biogas (CBG) capacity, which is expected to contribute to EBITDA from FY28. The rating also bolsters Trualt's diversification into the broader ethanol supply business and is expected to improve its access to capital for future funding needs.

Financial Performance

For the fiscal year 2025, Trualt Bioenergy reported consolidated revenue of ₹1,841.50 crore and consolidated EBITDA of ₹301.90 crore.

Potential Risks to Consider

The company's profitability could be affected if anticipated price increases for sugar-based ethanol are not realized. Margins for grain-based ethanol are also vulnerable to raw material price swings. Both ethanol and CBG businesses face inherent risks from government policy changes. Delays or cost overruns in capital expenditure projects could impact credit metrics. Pursuing large capital expenditure for Sustainable Aviation Fuel (SAF) without secured off-take agreements might weaken the credit profile.

Competitive Environment

Trualt Bioenergy operates in a dynamic market. Peers like Triveni Engineering & Industries also engage in sugar and distillery operations, making them direct competitors in the sugar-based ethanol market.

What to Watch Next

Investors will be monitoring the progress of the 21 planned CBG plants, particularly those under construction. Management's strategies for managing feedstock price volatility for grain-based ethanol will also be important. Developments and potential investment plans in the emerging Sustainable Aviation Fuel (SAF) segment are also key areas to track.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.